Why Novavax Stock Blasted 8% Higher Today
There's nothing like a surge in a deadly disease to encourage investors back into a noted healthcare stock. This dynamic benefited biotech (NASDAQ: NVAX) on Thursday.
It was also on the back of one pundit's recommendation upgrade; together these factors sent the company's share price 8% skyward. That performance trounced that of the S 500 index, which essentially traded sideways.
The latest COVID subvariant, Eris, is beginning to get significant coverage in the media. For instance, on the website of the TV news magazine Today, Eris was described as "sweeping" through this country.
Source Fool.com
Novavax Inc. Aktie
10,48 €
0,92 %
Leichtes Buy-Überwiegen bei Novavax Inc. im Vergleich zu Sell-Einschätzungen.
Das von der Community festgelegte Kursziel für Novavax Inc. von 22 € würde den aktuellen Kurs von 10.48 € mehr als verdoppeln.
